InvestorsHub Logo
Followers 78
Posts 24632
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 03/13/2024 8:22:32 AM

Wednesday, March 13, 2024 8:22:32 AM

Post# of 27550
NCNA - .38459 Pre-market at .8008/.805

NuCana shares are trading higher after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.